Oncology & Cancer

PSA levels no different with exposure to antidiabetes meds

(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to ...

Oncology & Cancer

Thirty percent fewer prostate cancer deaths with PSA screening

PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...

Oncology & Cancer

Early PSA testing could help predict prostate cancer among black men

Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It's more common—and more than twice as deadly—among black men compared to their white counterparts. ...

Oncology & Cancer

Precision-medicine approach could revive prostate cancer test

A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based ...

page 1 from 8